Classification of brain tumor extracts by high resolution 1H MRS using partial least squares discriminant analysis

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 2, 2011, Pages 149-164

  Faria, A V ^a,c   Macedo, F C ^b,d   Marsaioli, A J ^b   Ferreira, M M C ^b   Cendes, F ^b  

^a Departamento de Radiologia   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Brain; Magnetic resonance spectroscopy; Metabolism; Spectroscopy; Tumor

Indexed keywords

4 AMINOBUTYRIC ACID; ACETOACETIC ACID; ALANINE; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; TUMOR EXTRACT;

ADULT; AGED; APOPTOSIS; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CLASSIFICATION; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENERGY TRANSFER; GLIA; GLYCOLYSIS; HUMAN; IN VITRO STUDY; KETOGENESIS; METABOLITE; METASTASIS; OSMOTIC STRESS; PARTIAL LEAST SQUARES REGRESSION; PATTERN RECOGNITION; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR; TUMOR CELL; TURNOVER TIME;

EID: 79951488475     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500146     Document Type: Article

References (40)

1. American Cancer Society. http://www.cancer.org/.
2. Perry TL, Hansen S, Gandham SS. Postmortem changes of amino compounds in human and rat brain. J Neurochem 1981; 36: 406-410.
3. 1H MRS study of human high grade gliomas. NMR Biomed 2004; 17: 191-205.
4. Garcia-Gomez JM, Luts J, Julia-Sape M, Krooshof P, Tortajada S, Robledo JV, et al. Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy. MAGMA 2009; 22: 5-18.
5. Tate AR, Underwood J, Acosta DM, Julia-Sape M, Majos C, Moreno-Torres A, et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 2006; 19: 411-434.
6. Wright AJ, Arus C, Wijnen JP, Moreno-Torres A, Griffiths JR, Celda B, et al. Automated quality control protocol for MR spectra of brain tumors. Magn Reson Med 2008; 59: 1274-1281.
7. Julia-Sape M, Acosta D, Mier M, Arus C, Watson D. A multi-centre, web-accessible and quality control-checked database of in vivo MR spectra of brain tumour patients. MAGMA 2006; 19: 22-33.
8. 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors. NMR Biomed 2009; 22: 663-674.
9. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129-153.
10. Geladi P, Kowalski BR. Partial least squares regression: A tutorial. Anal Chim Acta 1986; 185: 1-17.
11. Ferreira MMC, Antunes AM, Melo MS, Volpe PLO. [Chemometrics I: multivariate calibration, a tutorial. Quím Nova 1999; 22: 724-731.
12. Sharipo A, Imreh M, Leonchiks A, Imreh S, Masucci MG. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat Med 1998; 4: 939-944.
13. Lemasters JJ, Qian T, He L, Kim JS, Elmore SP, Cascio WE, et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 2002; 4: 769-781.
14. 31P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed 2001; 14: 307-317.
15. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298.
16. Majos C, Aguilera C, Alonso J, Julia-Sape M, Castaner S, Sanchez JJ, et al. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol 2009; 30: 544-551.
17. 1H NMR spectroscopy. NMR Biomed 2005; 18: 413-420.
18. 1H MRS in human brain at 7 T. MAGMA 2009; 22: 1-4.
19. 1H NMR spectroscopic investigation. NMR Biomed 2005; 18: 371-382.
20. 13C-magnetic resonance spectroscopy observation in the human brain. Neuroreport 2005; 16: 2057-2060.
21. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-989.
22. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992; 24: 123-136.
23. Poptani H, Gupta RK, Jain VK, Roy R, Pandey R. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging 1995; 13: 1019-1029.
24. Demir MK, Iplikcioglu AC, Dincer A, Arslan M, Sav A. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 2006; 60: 48-55.
25. 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A 1984; 81: 6330-6334.
26. Bernasconi A, Tasch E, Cendes F, Li LM, Arnold DL. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res 2002; 135: 297-304.
27. Petroff OA, Errante LD, Kim JH, Spencer DD. N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus. Neurology 2003; 60: 1646-1651.
28. Gill M, Miller SL, Evans D, Scatliff JH, Meyerand ME, Powers SK, et al. Magnetic resonance imaging and spectroscopy of small ring-enhancing lesions using a rat glioma model. Invest Radiol 1994; 29: 301-306.
29. Simister RJ, McLean MA, Barker GJ, Duncan JS. Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy. Epilepsy Res 2007; 74: 107-115.
30. 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 1999; 34: 230-235.
31. 1H MRS choline: correlation with in vitro chemistry/ histology. Life Sci 1996; 58: 1929-1935.
32. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994; 18: 705-713.
33. Gallego-Ortega D, Ramirez De MA, Gutierrez R, Ramos MA, Sarmentero J, Cejas P, et al. Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer. Int J Oncol 2006; 29: 335-340.
34. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, et al. Regulation of tumor angiogenesis by p53- induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev 2000; 14: 34-44.
35. Gracey AY, Troll JV, Somero GN. Hypoxia-induced gene expression profiling in the euryoxic fish Gillichthys mirabilis. Proc Natl Acad Sci U S A 2001; 98: 1993-1998.
36. Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003; 278: 19575-19578.
37. Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A 2002; 99: 7021-7026.
38. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, et al. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 2001; 21: 3436-3444.
39. Petroff OA, Ogino T, Alger JR. High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem 1988; 51: 163-171.
40. Stanley JA, Cendes F, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 1998; 39: 267-273.